Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 155 clinical trials
SBRT With Combination Ipilimumab/Nivolumab for Metastatic Kidney Cancer (CYTOSHRINK)

This trial will evaluate the addition of cytoreductive stereotactic body radiation therapy (SBRT) to standard of care combination ipilimumab and nivolumab (I/N) versus I/N alone for the

nivolumab
ipilimumab
cancer
kidney cancer
metastasis
  • 1 views
  • 23 Apr, 2022
  • 6 locations
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT

This is a non-comparative open-label multicenter Phase 2 clinical trial combining stereotactic body radiation therapy (SBRT) and pembrolizumab with or without intratumoral SD-101 in patients

endocrine therapy
stereotactic body radiation therapy
serum bilirubin
erythropoietin
adenocarcinoma of prostate
  • 25 views
  • 05 Mar, 2022
  • 1 location
Quantitative MRI for Functional Assessment Following SBRT for Spinal Metastases

stereotactic body radiation therapy (SBRT) for painful metastatic spine disease.

cancer
stereotactic body radiation therapy
serum pregnancy test
spinal disease
metastasis
  • 0 views
  • 28 Feb, 2022
  • 1 location
SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer

The purpose of this study is to see if treatment with atezolizumab and stereotactic body radiation therapy (SBRT) will improve the objective response rate (ORR) compared with atezolizumab alone

MRI
metastatic cervical cancer
atezolizumab
cancer
squamous cell carcinoma
  • 38 views
  • 07 Jul, 2022
  • 2 locations
Study of Palliative Radiation Combined With Pembrolizumab in Unresectable Metastatic Stage IV Breast Cancer

This is a phase 2, open-label, single-arm trial designed to evaluate the efficacy and safety of stereotactic body radiation therapy (SBRT) in combination with pembrolizumab following disease

  • 0 views
  • 21 Nov, 2021
  • 1 location
Nano-SMART: Nanoparticles With MR Guided SBRT in Centrally Located Lung Tumors and Pancreatic Cancer

stereotactic body radiation therapy (SBRT) in the treatment of pancreatic cancer and lung tumors.

lung carcinoma
stereotactic body radiation therapy
  • 0 views
  • 08 Nov, 2021
  • 3 locations
Hepatic Ablation of Melanoma Metastases to Enhance Immunotherapy Response, a Phase I Clinical Trial (HAMMER I)

The primary purpose of this study is to determine the feasibility of liver stereotactic body radiation therapy (SBRT) given in combination with systemic therapy (ipilimumab and nivolumab) in

  • 0 views
  • 23 Sep, 2022
  • 1 location
SBRT +/- Pembrolizumab in Patients With Local-Regionally Recurrent or Second Primary Head and Neck Carcinoma (KEYSTROKE)

This phase II trial with a safety run-in component will evaluate whether the addition of pembrolizumab to Stereotactic Body Radiation Therapy (SBRT) re-irradiation will improve the progression

  • 2 views
  • 04 Oct, 2022
  • 19 locations
Y90 Radiation Segmentectomy vs SBRT for HCC

transarterial Y90 radioembolization (radiation segmentectomy) versus stereotactic body radiation therapy (SBRT) for solitary early stage ( 3cm) hepatocellular carcinoma (HCC).

serum bilirubin
  • 0 views
  • 08 Sep, 2021
  • 1 location
Urolift for Reduction of SBRT

Many patients may face long-term urinary side effects following stereotactic body radiation therapy (SBRT), including increased urinary frequency, dysuria, and nocturia. The investigator

Accepts healthy volunteers
cancer
transrectal ultrasound
  • 0 views
  • 04 Oct, 2022
  • 1 location